Jazz Pharmaceuticals' rare liver disorder drug wins U.S. approval

(Reuters) - The U.S. Food and Drug Administration has cleared Jazz Pharmaceuticals Plc's drug to treat a rare kind of liver disease, making it the first treatment to win U.S. approval for the condition.

http://ift.tt/1TiOrke

from Reuters: Health News
via animenewspro